open access

Vol 6, No 3 (2017)
REVIEW ARTICLES
Published online: 2017-09-29
Get Citation

Diabetic enteropathy — still undefeated?

Aleksandra Tomaszewska, Beata Mrozikiewicz-Rakowska, Leszek Czupryniak
DOI: 10.5603/DK.2017.0017
·
Clinical Diabetology 2017;6(3):105-110.

open access

Vol 6, No 3 (2017)
REVIEW ARTICLES
Published online: 2017-09-29

Abstract

Diabetic enteropathy is a specific diabetic complica­tion. It could be presented as constipations, diarrhoea or faecal incontinence. The aetiology is multifactorial. The main role is attributed to irreversible autonomic neuropathy, which often coexists with peripheral sen­sorimotor neuropathy. Nowadays, enteropathy is diag­nosed after exclusion of other causes, like coeliac dis­ease, hypo- or hyperthyroidism, inflammatory bowel disease, small intestinal bacterial overgrowth, exocrine pancreatic insufficiency and adverse drug reaction. The article presents new reports about enteropathy reversibility after simultaneous pancreas-kidney trans­plantation in patients with abnormal levels of IGF-1 and IGFBP3. It provides new data on pathogenesis of enteropathy and presents new diagnostic and thera­peutic approaches. (Clin Diabetol 2017; 6, 3: 105–110)

Abstract

Diabetic enteropathy is a specific diabetic complica­tion. It could be presented as constipations, diarrhoea or faecal incontinence. The aetiology is multifactorial. The main role is attributed to irreversible autonomic neuropathy, which often coexists with peripheral sen­sorimotor neuropathy. Nowadays, enteropathy is diag­nosed after exclusion of other causes, like coeliac dis­ease, hypo- or hyperthyroidism, inflammatory bowel disease, small intestinal bacterial overgrowth, exocrine pancreatic insufficiency and adverse drug reaction. The article presents new reports about enteropathy reversibility after simultaneous pancreas-kidney trans­plantation in patients with abnormal levels of IGF-1 and IGFBP3. It provides new data on pathogenesis of enteropathy and presents new diagnostic and thera­peutic approaches. (Clin Diabetol 2017; 6, 3: 105–110)

Get Citation

Keywords

diabetes, diabetic enteropathy, diabetic autonomic neuropathy, diabetic diarrhoea, faecal incontinence

About this article
Title

Diabetic enteropathy — still undefeated?

Journal

Clinical Diabetology

Issue

Vol 6, No 3 (2017)

Pages

105-110

Published online

2017-09-29

DOI

10.5603/DK.2017.0017

Bibliographic record

Clinical Diabetology 2017;6(3):105-110.

Keywords

diabetes
diabetic enteropathy
diabetic autonomic neuropathy
diabetic diarrhoea
faecal incontinence

Authors

Aleksandra Tomaszewska
Beata Mrozikiewicz-Rakowska
Leszek Czupryniak

References (24)
  1. Chandrasekharan B, Anitha M, Blatt R, et al. Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress. Neurogastroenterol Motil. 2011; 23(2): 131–138.
  2. Mashimo H, May RJ, Goyal RK. Joslin's diabetes mellitus. Lippincott Williams & Wilkins, Boston, 2005: 1069–1098.
  3. Lysy J, Israeli E, Goldin E. The prevalence of chronic diarrhea among diabetic patients. Am J Gastroenterol. 1999; 94(8): 2165–2170.
  4. Bytzer P, Talley NJ, Leemon M, et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001; 161(16): 1989–1996.
  5. Østergaard L, Finnerup NB, Terkelsen AJ, et al. The effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy. Diabetologia. 2015; 58(4): 666–677.
  6. Chung SSM, Ho ECM, Lam KSL, et al. Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol. 2003; 14(8 Suppl 3): S233–S236.
  7. Goldin A, Beckman JA, Schmidt AM, et al. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation. 2006; 114(6): 597–605.
  8. Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes. 1998; 47(6): 859–866.
  9. Bytzer P, Talley NJ, Hammer J, et al. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol. 2002; 97(3): 604–611.
  10. D'Addio F, La Rosa S, Maestroni A, et al. Circulating IGF-I and IGFBP3 Levels Control Human Colonic Stem Cell Function and Are Disrupted in Diabetic Enteropathy. Cell Stem Cell. 2015; 17(4): 486–498.
  11. Tafil-Klawe M, Klawe JJ. Wykłady z fizjologii człowieka. PZWL, Warszawa 2010: 960–990.
  12. Dooley CP, el Newihi HM, Zeidler A, et al. Abnormalities of the migrating motor complex in diabetics with autonomic neuropathy and diarrhea. Scand J Gastroenterol. 1988; 23(2): 217–223.
  13. Adamska A, Nowak M, Piłaciński S, et al. Częstość występowania zespołu rozrostu bakteryjnego jelita cienkiego (SIBO) u pacjentów z cukrzycą. Clinical Diabetology. 2015; 4(5): 175–182.
  14. Aitchison M, Fisher BM, Carter K, et al. Impaired anal sensation and early diabetic faecal incontinence. Diabet Med. 1991; 8(10): 960–963.
  15. Husby S, Koletzko S, Korponay-Szabó IR, et al. ESPGHAN Working Group on Coeliac Disease Diagnosis, ESPGHAN Gastroenterology Committee, European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012; 54(1): 136–160.
  16. Brock C, Brock B, Pedersen AG, et al. Assessment of the cardiovascular and gastrointestinal autonomic complications of diabetes. World J Diabetes. 2016; 7(16): 321–332.
  17. Farmer AD, Scott SM, Hobson AR. Gastrointestinal motility revisited: The wireless motility capsule. United European Gastroenterol J. 2013; 1(6): 413–421.
  18. Krishnan B, Babu S, Walker J, et al. Gastrointestinal complications of diabetes mellitus. World J Diabetes. 2013; 4(3): 51–63.
  19. Bharucha AE, Low P, Camilleri M, et al. A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation. Gut. 2013; 62(5): 708–715.
  20. Wald A, Tunuguntla AK. Anorectal sensorimotor dysfunction in fecal incontinence and diabetes mellitus. Modification with biofeedback therapy. N Engl J Med. 1984; 310(20): 1282–1287.
  21. Herman RM, Wałęga P. Widera A; Biofeedback jako zachowawcza metoda leczenia nietrzymania stolca. Przegl Lek. 2004; 61: 54–59.
  22. Herman RM, Wałęga P, Nowakowski M, et al. Transanal electrostimulation in the treatment of fecal incontinence following low anterior rectum resection. International Proceedings Division. 2001: 295–299.
  23. Sugrue J, Lehur PA, Madoff RD, et al. Long-term Experience of Magnetic Anal Sphincter Augmentation in Patients With Fecal Incontinence. Dis Colon Rectum. 2017; 60(1): 87–95.
  24. Karnafel W, Mrozikiewicz-Rakowska B. Zespół stopy cukrzycowej. Termedia, Poznań 2010: 34.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Diabetologia Kliniczna dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl